Cargando…

Bazedoxifene enhances the anti-tumor effects of cisplatin and radiation treatment by blocking IL-6 signaling in head and neck cancer

Recent studies have shown that IL-6 signaling plays an important role in the aggressive and metastatic phenotype of head and neck squamous cell carcinoma (HNSCC). Therefore, we hypothesized that targeting of IL-6 signaling in HNSCC could enhance the therapeutic efficacy of standard chemoradiation tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yadav, Arti, Kumar, Bhavna, Teknos, Theodoros N., Kumar, Pawan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620145/ https://www.ncbi.nlm.nih.gov/pubmed/28978005 http://dx.doi.org/10.18632/oncotarget.11464

Ejemplares similares

A Novel Curcumin Analog (H-4073) Enhances the Therapeutic Efficacy of Cisplatin Treatment in Head and Neck Cancer
por: Kumar, Bhavna, et al.
Publicado: (2014)

Dysregulation of MicroRNA-34a Expression in Head and Neck Squamous Cell Carcinoma Promotes Tumor Growth and Tumor Angiogenesis
por: Kumar, Bhavna, et al.
Publicado: (2012)

Suberoylanilide hydroxamic acid (SAHA) reverses chemoresistance in head and neck cancer cells by targeting cancer stem cells via the downregulation of nanog
por: Kumar, Bhavna, et al.
Publicado: (2015)

A muscle specific protein “myoferlin” modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus
por: Yadav, Arti, et al.
Publicado: (2017)

Interleukin-6 role in head and neck squamous cell carcinoma progression
por: Choudhary, Moaz M., et al.
Publicado: (2016)

Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis
por: Kumar, Pawan, et al.
Publicado: (2010)

Tumor-Associated Endothelial Cells Promote Tumor Metastasis by Chaperoning Circulating Tumor Cells and Protecting Them from Anoikis
por: Yadav, Arti, et al.
Publicado: (2015)

Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status
por: Kumar, Bhavna, et al.
Publicado: (2017)

RhoC Regulates Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma by Overexpressing IL-6 and Phosphorylation of STAT3
por: Islam, Mozaffarul, et al.
Publicado: (2014)

Novel therapeutics and emerging technologies in head and neck cancer
por: Teknos, Theodoros N.
Publicado: (2016)

ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma
por: Yoo, Ji Young, et al.
Publicado: (2015)

Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy
por: Xiao, Hui, et al.
Publicado: (2017)

Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Jaime-Ramirez, Alena C., et al.
Publicado: (2017)

Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008)

The current status of oncolytic viral therapy for head and neck cancer
por: Old, Matthew O., et al.
Publicado: (2016)

Molecular profiling of head and neck squamous cell carcinoma
por: Feldman, Rebecca, et al.
Publicado: (2015)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2011)

Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan
por: Ohta, H., et al.
Publicado: (2014)

Effects of lasofoxifene and bazedoxifene on B cell development and function
por: Bernardi, Angelina I, et al.
Publicado: (2014)

Bazedoxifene/conjugated estrogens in combination with leuprolide for the treatment of endometriosis
por: Hill, Amanda M., et al.
Publicado: (2018)

Effects of conjugated estrogen and bazedoxifene on hemostasis and thrombosis in mice
por: Noirrit, Emmanuelle, et al.
Publicado: (2019)

Home-based Application of Sphenopalatine Ganglion Block for Head and Neck Cancer Pain Management
por: Sanghavi, Priti R, et al.
Publicado: (2017)

Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer
por: Nowicki, PW, et al.
Publicado: (2009)

Identification of hub genes involved in cisplatin resistance in head and neck cancer
por: Chaudhary, Raushan Kumar, et al.
Publicado: (2023)

DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma
por: Smith, Eric A., et al.
Publicado: (2017)

Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma
por: Xie, Xiujie, et al.
Publicado: (2013)

Update on bazedoxifene: A novel selective estrogen receptor modulator
por: Biskobing, Diane M
Publicado: (2007)

Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
por: Komm, Barry S, et al.
Publicado: (2012)

Bazedoxifene as a novel strategy for treatment of pancreatic and gastric adenocarcinoma
por: Burkhardt, Claudia, et al.
Publicado: (2019)

Bazedoxifene Suppresses Intracellular Mycobacterium tuberculosis Growth by Enhancing Autophagy
por: Ouyang, Qi, et al.
Publicado: (2020)

Bazedoxifene does not share estrogens effects on IgG sialylation
por: Gupta, Priti, et al.
Publicado: (2023)

Long term results of comparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer
por: Gupta, Pramod Kumar, et al.
Publicado: (2016)

Inhibition of Interleukin‐6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice
por: Shi, Wei, et al.
Publicado: (2020)

High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status
por: Kumar, Bhavna, et al.
Publicado: (2016)

IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives
por: Španko, Michal, et al.
Publicado: (2021)

Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination
por: Mirkin, Sebastian, et al.
Publicado: (2013)

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
por: Darbà, Josep, et al.
Publicado: (2013)

Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene
por: Kagan, Risa, et al.
Publicado: (2016)

The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause
por: Lello, Stefano, et al.
Publicado: (2017)

Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
por: Wei, Jia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vqrlcuabmbkp8kc2rfqi8jqs3c